ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

2025, Vol 15, No. 1

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. Protective Effect of Prosopis cineraria Against N-Nitrosodiethylamine Induced Liver Tumor by Modulating Membrane Bound Enzymes and Glycoproteins

NAINA MOHAMED PAKKIR MAIDEEN*, RAVICHANDIRAN VELAYUTHAM, GOBINATH MANAVALAN

Adv Pharm Bull. 2012;2(2): 179-182. doi: 10.5681/apb.2012.027

PMCID: PMC3845991 PMID: 24312790 Scopus ID: 84875912104

Article

PDF

XML

Cited By:

Research Article

2. The Effects of Natural Clinoptilolite and Nano-Sized Clinoptilolite Supplementation on Lipid Profile, Food Intakes and Body Weight in Rats with Streptozotocin-Induced Diabetes

Behnoush Hossein-Nia, Sirous Khorram, Hassan Rezazadeh, Abdolrasol Safaiyan, Rafighe Ghiasi, Ali Tarighat-Esfanjani*

Adv Pharm Bull. 2018;8(2): 211-216. doi: 10.15171/apb.2018.025

PMCID: PMC6046415 PMID: 30023322 Scopus ID: 85048875298

Article

PDF

XML

Cited By:

Research Article

3. Interaction of Coenzyme Q10 with Liposomes and its Impact on Suppression of Selenite – Induced Experimental Cataract

Medhat Wahba Shafaa*, Amany Hasan Elshazly, Amira Zaki Dakrory, Maha Reda Elsyed

Adv Pharm Bull. 2018;8(1): 1-9. doi: 10.15171/apb.2018.001

PMCID: PMC5896383 PMID: 29670833 Scopus ID: 85044032923

Article

PDF

XML

Cited By:

Review Article

4. Signaling Pathways of Receptors Involved in Platelet Activation andShedding of These Receptors in Stored Platelets

Asra Amelirad , Karim Shamsasenjan* , Parvin Akbarzadehlaleh , Davoud Pashoutan Sarvar

Adv Pharm Bull. 2019;9(1): 38-47. doi: 10.15171/apb.2019.005

PMCID: PMC6468227 PMID: 31011556 Scopus ID: 85065989465

Article

PDF

XML

Cited By:

Research Article

5. Phosphorylation Modulates Survivin Function in Behcet’s Disease

Yasamin Pahlavan , Naser Samadi, Khalil Ansarin, Alireza Khabbazi*

Adv Pharm Bull. 2020;10(2): 278-283. doi: 10.34172/apb.2020.033

PMCID: PMC7191240 PMID: 32373497 Scopus ID: 85088706970

Article

PDF

Full Text

XML

Cited By:

Research Article

6. Recombinant Expression and Biophysical Characterization of a Druggable Schistosoma mansoni Universal Stress G4LZI3 Protein

Abiola Fatimah Adenowo* , Priscilla Masamba, Ndibonani Kebonang Qokoyi, Babatunji Emmanuel Oyinloye, Abidemi Paul Kappo

Adv Pharm Bull. 2022;12(2): 366-374. doi: 10.34172/apb.2022.035

PMCID: PMC9106952 PMID: 35620338 Scopus ID: 85128214095

Article

PDF

Full Text

XML

Cited By:

Review Article

7. Recent Progress in the Oral Delivery of Therapeutic Peptides and Proteins: Overview of Pharmaceutical Strategies to Overcome Absorption Hurdles

Sonal Mehrotra, Pavan Kalyan BG, Pawan Ganesh Nayak, Alex Joseph, Jyothsna Manikkath*

Adv Pharm Bull. 2024;14(1): 11-33. doi: 10.34172/apb.2024.009

PMCID: PMC10997937 PMID: 38585454

Article

PDF

Full Text

XML

Cited By:

Original Article

8. Safety and Feasibility of Blockade of NK Group-2 Member-A Receptor in Natural Killer Cells Combined with Cetuximab Antibody in Patients with Advanced Gastric Adenocarcinoma

Maryam Samareh-Salavatipour , Shirin Tavakoli , Maryam Barkhordar, Iman Seyhoun*, Nasim Vousooghi, Mohammad Vaezi, Afshin Ghaderi, Tahereh Bakhtiari, Ardeshir Ghavamzadeh, Javad Verdi* , Mohammad Ahmadvand*

Adv Pharm Bull. 2025;15(1): 143-153. doi: 10.34172/apb.43859

Article

PDF

XML

Cited By: